ImportRefusal LogoImportRefusal

Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory)

⚠️ High Risk

FEI: 3012333115 • Hwaseong, Gyeonggi • SOUTH KOREA

FEI

FEI Number

3012333115

📍

Location

Hwaseong, Gyeonggi

🇰🇷
🏢

Address

Hyangnam-Eub, 35-14 Jeyakgongdan4-Gil; Hyangnam-Eup, Hwaseong, Gyeonggi, South Korea

High Risk

FDA Import Risk Assessment

53.6
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

3
Total Refusals
4
Unique Violations
1/20/2026
Latest Refusal
6/13/2024
Earliest Refusal

Score Breakdown

Violation Severity
66.7×40%
Refusal Volume
22.3×30%
Recency
92.0×20%
Frequency
18.7×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

753×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

4721×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

Refusal History

DateProductViolationsDivision
1/20/2026
58PCZ05ONABOTULINUMTOXINA
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/30/2025
58PCZ05ONABOTULINUMTOXINA
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/13/2024
58PCP05ONABOTULINUMTOXINA
472NO ENGLISH
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory)'s FDA import refusal history?

Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory) (FEI: 3012333115) has 3 FDA import refusal record(s) in our database, spanning from 6/13/2024 to 1/20/2026.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory)'s FEI number is 3012333115.

What types of violations has Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory) received?

Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory) has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory) come from?

All FDA import refusal data for Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory) is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.